Opposing GST exorbitant rates on cancer drugs and other life-saving treatments, the Indian Medical Association (IMA) welcomed the relief. The note of relief happened due to the slashing of GST on cancer treatment drugs by the GST Council. The reduction is a significant, upfront measure in reducing the financial impact of the treatment on the patient and a major encouragement to universal access to treatment in a timely manner.
The central point of all high-cost treatments in India has been the spiraling drug costs which have caused pain to the patients struggling through an ailment and hardships for the families. A slash in GST has actually affected this direct pain. Apparently, had this not come at all, the move would ease pain on patients and nullify imprisonment-draining pads for timely medical care.
IMA then thanked the government, affirming any lowering of prices to go directly in the interest of patients. It stood clear that the GST rate revision would help greatly individuals of middle-income groups and even lower-income families who gruel to pay for medical treatments running into long-term dependency. The subtext also read: This initiative is aa patient-centric in a health system policy.
Down by 50%
The cut also affected essential drugs used to treat normally chronic and multinational diseases-these include cardiovascular disorders, diseases of the kidneys, and rare genetic disorders. In other words, many will be relieved from the burden of recurring medical costs.
Impact on a Large Canvas
Medical administrators hope that this would lead to a better treatment compliance in patients by giving them their best shot at completing the prescribed drug treatment due to reduced cost considerations. On the other hand, public health planners think this prescription aligns with the broader vision of making Indian healthcare system accessible to everyone.
ALSO READ: Government’s GST Cut to Make Home Construction Cheaper
INDIAN Medical Association (IMA) has thus come in support of the GST Council decision to reduce the immense pressure on cancer patients and their families. They applaud the stand for making healthcare affordable–and patient-centric.